These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 16043262

  • 1. Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer.
    Kim DW, Shyr Y, Shaktour B, Akerley W, Johnson DH, Choy H.
    Lung Cancer; 2005 Nov; 50(2):235-45. PubMed ID: 16043262
    [Abstract] [Full Text] [Related]

  • 2. Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer.
    Kim DW, Shyr Y, Chen H, Akerley W, Johnson DH, Choy H.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1029-36. PubMed ID: 15913910
    [Abstract] [Full Text] [Related]

  • 3. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
    McAleer MF, Moughan J, Byhardt RW, Cox JD, Sause WT, Komaki R.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):802-8. PubMed ID: 19540055
    [Abstract] [Full Text] [Related]

  • 4. [Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
    Ren H, Wang LH, Wang XZ, Lü JM, Ji W, Zhou ZM, Ou GF, Yin WB.
    Zhonghua Zhong Liu Za Zhi; 2009 Feb 01; 31(2):143-7. PubMed ID: 19538894
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR, SWOG S9712.
    J Clin Oncol; 2006 Nov 20; 24(33):5242-6. PubMed ID: 17114656
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study.
    Jeremić B, Milicić B, Acimović L, Milisavljević S.
    J Clin Oncol; 2005 Oct 01; 23(28):6873-80. PubMed ID: 16192579
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
    Choy H, Nabid A, Stea B, Scott C, Roa W, Kleinberg L, Ayoub J, Smith C, Souhami L, Hamburg S, Spanos W, Kreisman H, Boyd AP, Cagnoni PJ, Curran WJ.
    J Clin Oncol; 2005 Sep 01; 23(25):5918-28. PubMed ID: 16135463
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer.
    Iranzo V, Bremnes RM, Almendros P, Gavilá J, Blasco A, Sirera R, Camps C.
    Lung Cancer; 2009 Jan 01; 63(1):63-7. PubMed ID: 18550204
    [Abstract] [Full Text] [Related]

  • 17. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
    Machtay M, Hsu C, Komaki R, Sause WT, Swann RS, Langer CJ, Byhardt RW, Curran WJ.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):667-71. PubMed ID: 15927409
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.
    Tell R, Sederholm C, Klintenberg C, Franksson L, Brandén E, Hillerdal G, Lönn U, Lindén CJ, Ewers SB, Lamberg K, Mrazek E, Lödén B, Sjögren A, Linné T, Friesland S, Sirzén F.
    Anticancer Res; 2008 Nov 01; 28(5B):2851-7. PubMed ID: 19031924
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.